{"id":9667,"date":"2026-03-18T11:22:37","date_gmt":"2026-03-18T03:22:37","guid":{"rendered":"https:\/\/regask.com\/?p=9667"},"modified":"2026-03-18T11:22:37","modified_gmt":"2026-03-18T03:22:37","slug":"griechenland-offnet-plattform-fur-echtheitszertifikate-auf-arzneimittelverpackungen-wieder","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","title":{"rendered":"Griechenlands EOF er\u00f6ffnet Plattform f\u00fcr Echtheitspr\u00fcfungsband wieder\u2026"},"content":{"rendered":"<p><span data-contrast=\"auto\">An\u00a0<\/span><b><span data-contrast=\"auto\">9. M\u00e4rz 2026<\/span><\/b><span data-contrast=\"auto\">, Die Nationale Organisation f\u00fcr Arzneimittel gab die vor\u00fcbergehende Wiederer\u00f6ffnung ihrer digitalen Einreichungsplattform f\u00fcr die\u00a0<\/span><b><span data-contrast=\"auto\">Echtheitszertifikate auf pharmazeutischen Verpackungen<\/span><\/b><span data-contrast=\"auto\">. Das Update zielt speziell darauf ab\u00a0<\/span><b><span data-contrast=\"auto\">Inhaber der Marktzulassung (MAHs)<\/span><\/b><span data-contrast=\"auto\">\u00a0Und\u00a0<\/span><b><span data-contrast=\"auto\">lokale Vertreter, die f\u00fcr in Griechenland vermarktete Arzneimittel zust\u00e4ndig sind<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Das Einreichungsfenster ist ge\u00f6ffnet vom\u00a0<\/span><b><span data-contrast=\"auto\">9. M\u00e4rz 2026 um 08:00 Uhr bis 10. M\u00e4rz 2026 um 23:59 Uhr<\/span><\/b><span data-contrast=\"auto\">, wodurch die Beteiligten die Authentizit\u00e4t der B\u00e4nder erkl\u00e4ren konnten, die\u00a0<\/span><b><span data-contrast=\"auto\">bereits auf pharmazeutische Verpackungen angewendet, aber nicht bis zum urspr\u00fcnglichen gesetzlichen Stichtag am 20. Februar 2026 gemeldet wurden.<\/span><\/b><span data-contrast=\"auto\">. Diese Initiative ist Teil der Durchsetzungsma\u00dfnahmen der EOF.\u00a0<\/span><b><span data-contrast=\"auto\">Arzneimittelserienverwaltung und Vorschriften zur Bek\u00e4mpfung von Produktf\u00e4lschungen<\/span><\/b><span data-contrast=\"auto\">\u00a0gem\u00e4\u00df den geltenden griechischen Gesetzen.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<div class=\"row\"  id=\"row-275275305\">\n\n\t<div id=\"col-94194575\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-1046168601\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1046168601 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Details zum Update<\/h2>\n\t<div id=\"gap-86742456\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-86742456 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Die wiederer\u00f6ffnete Plattform bietet eine\u00a0<\/span><b><span data-contrast=\"auto\">Begrenzte M\u00f6glichkeit zur doppelten Best\u00e4tigung der Echtheitsaufzeichnung des Tonbandes<\/span><\/b><span data-contrast=\"auto\">. Diese Ma\u00dfnahme erm\u00f6glicht es Zulassungsinhabern und lokalen Vertretern, Erkl\u00e4rungen f\u00fcr Tonb\u00e4nder einzureichen, die zuvor in den bis zum [Datum einf\u00fcgen] f\u00e4lligen Einreichungen nicht ber\u00fccksichtigt wurden.\u00a0<\/span><b><span data-contrast=\"auto\">Frist: 20. Februar 2026<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Das Deklarationsfenster ist streng beschr\u00e4nkt auf\u00a0<\/span><b><span data-contrast=\"auto\">Authentizit\u00e4tsb\u00e4nder, die bereits auf pharmazeutischen Verpackungen angebracht wurden<\/span><\/b><span data-contrast=\"auto\">\u00a0Sie wurden jedoch im urspr\u00fcnglichen Meldezeitraum nicht gemeldet. Neue Antr\u00e4ge fallen nicht unter diese Wiederer\u00f6ffnung.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">EOF betont, dass\u00a0<\/span><b><span data-contrast=\"auto\">Die unverz\u00fcgliche und vollst\u00e4ndige Einhaltung der Vorschriften ist erforderlich.<\/span><\/b><span data-contrast=\"auto\">, mit dem Hinweis, dass das fortgesetzte Vers\u00e4umnis, Authentizit\u00e4tsb\u00e4nder zu melden, dazu f\u00fchren kann,\u00a0<\/span><b><span data-contrast=\"auto\">Regulierungsma\u00dfnahmen oder Strafen<\/span><\/b><span data-contrast=\"auto\">. Das Update unterstreicht den Fokus der Regulierungsbeh\u00f6rde auf\u00a0<\/span><b><span data-contrast=\"auto\">R\u00fcckverfolgbarkeit, Produktauthentizit\u00e4t und F\u00e4lschungsschutzma\u00dfnahmen innerhalb der pharmazeutischen Lieferkette in Griechenland<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-94194575 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-614401818\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Feedback-Frist<\/h2>\n\t<div id=\"gap-1601397117\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1601397117 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">Die EOF-Einreichungsplattform zur Erkl\u00e4rung bisher nicht gemeldeter Echtheitsb\u00e4nder bleibt ge\u00f6ffnet.\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">aus <strong>09. M\u00e4rz 2026 (08:00) bis 10. M\u00e4rz 2026 (23:59)<\/strong><\/span><\/span><strong><span class=\"TextRun SCXW230829425 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW230829425 BCX0\">.<\/span><\/span><span class=\"EOP SCXW230829425 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-614401818 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-934665920\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Warum es wichtig ist<\/h2>\n\t<div id=\"gap-521120214\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-521120214 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Dieses Update st\u00e4rkt die regulatorische Aufsicht in Bezug auf <strong>Serialisierung und Einhaltung der F\u00e4lschungsschutzbestimmungen<\/strong> auf dem griechischen Pharmamarkt. Durch die Bereitstellung einer kurzen Wiederer\u00f6ffnungsfrist f\u00fcr Meldungen unterst\u00fctzt EOF eine verbesserte <strong>Datengenauigkeit, R\u00fcckverfolgbarkeit und Transparenz der Lieferkette,<\/strong> unter Beibehaltung <strong>regulatorische Konsistenz und minimale betriebliche St\u00f6rungen<\/strong> f\u00fcr betroffene Unternehmen.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-934665920 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-839572762\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>F\u00fcr wen ist das relevant?<\/h2>\n\t<div id=\"gap-1871850531\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1871850531 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Die Ank\u00fcndigung ist besonders relevant f\u00fcr <strong>Zulassungsinhaber, lokale Pharmareferenten, Zulassungsteams, Qualit\u00e4tssicherungsexperten und Compliance-Teams<\/strong> verantwortlich f\u00fcr die <strong>Vertrieb, Meldewesen und beh\u00f6rdliche Aufsicht \u00fcber Arzneimittel in Griechenland. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-839572762 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1432916065\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>N\u00e4chste Schritte<\/h2>\n\t<div id=\"gap-1035724712\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1035724712 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Die Regulierungsbeh\u00f6rden sollten\u00a0<\/span><b><span data-contrast=\"auto\">\u00dcberpr\u00fcfung der Aufzeichnungen von Echtheitsbandanwendungen<\/span><\/b><span data-contrast=\"auto\">\u00a0und \u00fcberpr\u00fcfen Sie sie gegen\u00a0<\/span><b><span data-contrast=\"auto\">fr\u00fchere Einreichungen vor dem Stichtag am 20. Februar 2026<\/span><\/b><span data-contrast=\"auto\">. Etwaige Auslassungen sollten umgehend erkannt und die erforderlichen Erkl\u00e4rungen \u00fcber die EOF-Plattform eingereicht werden.\u00a0<\/span><b><span data-contrast=\"auto\">innerhalb des Wiederer\u00f6ffnungszeitraums vom 9. bis 10. M\u00e4rz 2026<\/span><\/b><span data-contrast=\"auto\">\u00a0um potenzielle Compliance-Risiken zu vermeiden.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Organisationen, die in mehreren regulierten M\u00e4rkten t\u00e4tig sind, sehen sich h\u00e4ufig mit \u00e4hnlichen, kurzfristigen regulatorischen Aktualisierungen konfrontiert. Plattformen wie beispielsweise\u00a0<\/span><b><span data-contrast=\"auto\">RegASK<\/span><\/b><span data-contrast=\"auto\">\u00a0Unterst\u00fctzung von Compliance- und Regulierungsteams bei der \u00dcberwachung von \u00c4nderungen, der Verfolgung von Verpflichtungen und der Optimierung von Einreichungen \u00fcber verschiedene Rechtsordnungen hinweg.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/de\/\"><strong>RegASK<\/strong><\/a>\u00a0ist eine f\u00fchrende agentenbasierte KI-Plattform f\u00fcr regulatorische Analysen und Workflow-Orchestrierung, die globale Unternehmen in stark regulierten Branchen wie Konsumg\u00fcter und Life Sciences dabei unterst\u00fctzt, sich proaktiv in komplexen regulatorischen Umfeldern zu bewegen. Durch die Kombination von fortschrittlicher agentenbasierter KI mit Expertenwissen,\u00a0<a href=\"http:\/\/regask.com\/de\/\"><strong>RegASK<\/strong><\/a>\u00a0liefert zeitnahe, vorausschauende und umsetzbare Erkenntnisse sowie eine durchg\u00e4ngige Automatisierung, optimiert Compliance-Prozesse, mindert Risiken und beschleunigt den Marktzugang in mehr als 160 L\u00e4ndern. <a href=\"http:\/\/regask.com\/de\/\"><strong>Mehr erfahren <\/strong><\/a>oder<a href=\"https:\/\/regask.com\/de\/demo-buchen\/\"><strong> Jetzt Demo buchen.<\/strong><\/a><\/span><strong>\u00a0<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1432916065 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1983460007\">\n\n\t<div id=\"col-681152692\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>FAQs<\/h3>\n\t<div id=\"gap-1221225378\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1221225378 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW267956491 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW267956491 BCX0\" data-ccp-parastyle=\"heading 3\">Was besagt die neue CDE-Leitlinie zu klinischen Studien mit Grippeimpfstoffen?<\/span><\/span><span class=\"EOP SCXW267956491 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1351714257\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1351714257 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><strong>Portfolio- und Technologie-Meetings (PTMs)<\/strong> sind strukturierte virtuelle Meetings, die von der <strong>Europ\u00e4ische Arzneimittel-Agentur<\/strong> um gro\u00dfen Pharmaunternehmen die M\u00f6glichkeit zu geben, zu diskutieren <strong>Herausforderungen bei der Entwicklung des Produktportfolios und neue Technologien<\/strong> mit der Regulierungsbeh\u00f6rde.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-681152692 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-790913786\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW184197477 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW184197477 BCX0\" data-ccp-parastyle=\"heading 3\">Wer kann sich f\u00fcr die EMA Portfolio- und Technologie-Meetings bewerben?<\/span><\/span><span class=\"EOP SCXW184197477 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-2063339315\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2063339315 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Das PTM-Programm steht offen f\u00fcr <strong>gro\u00dfe Pharmaunternehmen mit umfangreichen Produktportfolios an Arzneimitteln.<\/strong> Antragsberechtigte Unternehmen m\u00fcssen ein Antragsformular zur Pr\u00fcfung bei der EMA einreichen.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-790913786 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1902253553\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW3460145 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW3460145 BCX0\" data-ccp-parastyle=\"heading 3\">Wann ist die Bewerbungsfrist f\u00fcr ein PTM im Jahr 2026?<\/span><\/span><span class=\"EOP SCXW3460145 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1877575819\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1877575819 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Der <strong>Bewerbungsschluss ist der 30. April 2026.<\/strong> Der <strong>Die EMA wird die Ergebnisse der Antr\u00e4ge bis Ende Mai 2026 mitteilen.,<\/strong> und genehmigte Treffen finden statt in <strong>zweite Jahresh\u00e4lfte 2026. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1902253553 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1397043294\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW14904628 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">Wie kann\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">RegASK<\/span><span class=\"NormalTextRun SCXW14904628 BCX0\" data-ccp-parastyle=\"heading 3\">\u00a0Wie k\u00f6nnen Organisationen solche Aktualisierungen verwalten?<\/span><\/span><span class=\"EOP SCXW14904628 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-516301575\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-516301575 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/de\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW253285960 BCX0\">RegASKs<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0<strong>agentic KI-Plattform f\u00fcr regulatorische Intelligenz<\/strong><\/span><\/span><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">hilft Pharmaunternehmen\u00a0<\/span><\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">Monitor<\/span><strong><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">Globale regulatorische Ank\u00fcndigungen, Beteiligungsm\u00f6glichkeiten und Konsultationsprogramme<\/span><\/span><\/strong><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0in Echtzeit. Dies erm\u00f6glicht es den Regulierungsbeh\u00f6rden,\u00a0<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">identifizieren<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0Initiativen wie zum Beispiel\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\">EMA-Portfolio- und Technologietreffen<\/span><\/span><\/strong><span class=\"TextRun SCXW253285960 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW253285960 BCX0\"><strong>,<\/strong> interne Vorbereitung koordinieren und\u00a0<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">pflegen<\/span><span class=\"NormalTextRun SCXW253285960 BCX0\">\u00a0Bereitschaft zur Einhaltung von Vorschriften in komplexen globalen Pipelines.<\/span><\/span><span class=\"EOP SCXW253285960 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1397043294 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On\u00a0March 9, 2026, the National Organization for Medicines announced the temporary reopening of its digital submission platform for the\u00a0declaration of authenticity tapes affixed to pharmaceutical packaging. The update specifically targets\u00a0Marketing Authorization Holders (MAHs)\u00a0and\u00a0local representatives responsible for medicines marketed in Greece.\u00a0 The submission window is open from\u00a009 March 2026 at 08:00 to 10 March 2026 at&#8230;<\/p>","protected":false},"author":43,"featured_media":9668,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,35,556],"tags":[],"class_list":["post-9667","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-pharma-biotech-latest-insights","category-greece-regulations"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Greece\u2019s EOF Reopens Platform for Compliance Updates<\/title>\n<meta name=\"description\" content=\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/griechenland-offnet-plattform-fur-echtheitszertifikate-auf-arzneimittelverpackungen-wieder\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Greece\u2019s EOF Reopens Platform for Authenticity Tape Declarations on Pharmaceutical Packaging\" \/>\n<meta property=\"og:description\" content=\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/griechenland-offnet-plattform-fur-echtheitszertifikate-auf-arzneimittelverpackungen-wieder\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-18T03:22:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"Greece\u2019s EOF Reopens Platform for Authenticity Tape D&hellip;\",\"datePublished\":\"2026-03-18T03:22:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"},\"wordCount\":822,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"articleSection\":[\"Regulatory News\",\"Pharma and Biotech\",\"Greece\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\",\"name\":\"Greece\u2019s EOF Reopens Platform for Compliance Updates\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"datePublished\":\"2026-03-18T03:22:37+00:00\",\"description\":\"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png\",\"width\":800,\"height\":600,\"caption\":\"Greece Eof Reopens Platform Authenticity Tape Declarations Pharmaceutical Packaging\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Griechenlands EOF \u00f6ffnet Plattform f\u00fcr Compliance-Aktualisierungen wieder","description":"Die griechische EOF \u00f6ffnet die Plattform f\u00fcr Echtheitszertifikate auf Arzneimittelverpackungen vom 9. M\u00e4rz bis zum 10. M\u00e4rz 2026 wieder.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/griechenland-offnet-plattform-fur-echtheitszertifikate-auf-arzneimittelverpackungen-wieder\/","og_locale":"de_DE","og_type":"article","og_title":"Greece\u2019s EOF Reopens Platform for Authenticity Tape Declarations on Pharmaceutical Packaging","og_description":"Greece\u2019s EOF reopens the platform for authenticity tape declarations on pharmaceutical packaging from March 9 to March 10, 2026.","og_url":"https:\/\/regask.com\/de\/griechenland-offnet-plattform-fur-echtheitszertifikate-auf-arzneimittelverpackungen-wieder\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-03-18T03:22:37+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#article","isPartOf":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"Greece\u2019s EOF Reopens Platform for Authenticity Tape D&hellip;","datePublished":"2026-03-18T03:22:37+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"},"wordCount":822,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","articleSection":["Regulatory News","Pharma and Biotech","Greece"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","url":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/","name":"Griechenlands EOF \u00f6ffnet Plattform f\u00fcr Compliance-Aktualisierungen wieder","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","datePublished":"2026-03-18T03:22:37+00:00","description":"Die griechische EOF \u00f6ffnet die Plattform f\u00fcr Echtheitszertifikate auf Arzneimittelverpackungen vom 9. M\u00e4rz bis zum 10. M\u00e4rz 2026 wieder.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/greeces-eof-reopens-platform-for-authenticity-tape-declarations-on-pharmaceutical-packaging\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/greece-eof-reopens-platform-authenticity-tape-declarations-pharmaceutical-packaging.png","width":800,"height":600,"caption":"Greece Eof Reopens Platform Authenticity Tape Declarations Pharmaceutical Packaging"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/9667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=9667"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/9667\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/9668"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=9667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=9667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=9667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}